Hepatocellular carcinoma (HCC) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`None`

ID	`IND-VHL-CARRIER-SURVEILLANCE`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-HCC`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB — v0.2-B VHL confirmed-carrier surveillance pathway. Two-Clinical-Co-Lead signoff queued per CHARTER §6.1 dev-mode.

Used By

Actionability

BMA-METANEPHRINES-PHEO-VHL-MEN2-SURVEILLANCE - Plasma free metanephrines are the gold-standard biochemical test for pheochromocytoma and...

Algorithms

ALGO-VHL-CARRIER-SURVEILLANCE-VHL-ALLIANCE - ALGO-VHL-CARRIER-SURVEILLANCE-VHL-ALLIANCE

Indication

IND-CASCADE-VHL-FDR-POSITIVE-TESTING - IND-CASCADE-VHL-FDR-POSITIVE-TESTING
IND-VHL-CARRIER-INTENSIFIED - IND-VHL-CARRIER-INTENSIFIED

Red flag

RF-VHL-FAMILY-HISTORY-SUSPICION - Family pedigree suggestive of Von Hippel-Lindau (VHL) disease: any of (a) a family member...